
Reset all filters
01 1Allergan Inc.
02 2Gowling WLG (Canada) LLP
Reset all filters
01 12713254
02 22745084
Reset all filters
01 3ULIPRISTAL ACETATE
Reset all filters
01 3TABLET
Reset all filters
01 12029-01-28
02 22029-12-08
Patent Expiration Date : 2029-01-28
Date Granted : 2014-10-07
Brand Name : FIBRISTAL
Patent Number : 2713254
Filing Date : 2009-01-28
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-01-28
Date Granted : 2014-10-07
Patent Expiration Date : 2029-12-08
Date Granted : 2014-11-18
Brand Name : FIBRISTAL
Patent Number : 2745084
Filing Date : 2009-12-08
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-12-08
Date Granted : 2014-11-18
Patent Expiration Date : 2029-12-08
Date Granted : 2014-11-18
Brand Name : ELLA
Patent Number : 2745084
Filing Date : 2009-12-08
Strength per Unit : 30 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-12-08
Date Granted : 2014-11-18